Treatment of hepatitis C in HIV-infected persons: A work in progress

Journal of Hepatology

Volumn 48, Issue 1, 2008, Pages 5-7

  Sulkowski, Mark ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IDOXURIDINE; PEGINTERFERON; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN;

CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DISEASE ASSOCIATION; DRUG SAFETY; EDITORIAL; HEALTH SURVEY; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MORBIDITY; MORTALITY; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ANTI-HIV AGENTS; HEPATITIS C; HIV INFECTIONS; HUMANS; LIVER; RNA, VIRAL;

EID: 36549044419     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.10.006     Document Type: Editorial

References (16)

1. Weber R., Sabin C.A., Friis-Moller N., Reiss P., El Sadr W.M., Kirk O., et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med 166 (2006) 1632-1641
2. Chung R.T., Andersen J., Volberding P., Robbins G.K., Liu T., Sherman K.E., et al. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med 351 (2004) 451-459
3. Carrat F., Bani-Sadr F., Pol S., Rosenthal E., Lunel-Fabiani F., Benzekri A., et al. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA 292 (2004) 2839-2848
4. Nunez M., Miralles C., Berdun M.A., Losada E., Aguirrebengoa K., Ocampo A., et al. Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial. AIDS Res Hum Retroviruses 23 (2007) 972-982
5. Laguno M., Murillas J., Blanco J.L., Martinez E., Miquel R., Sanchez-Tapias J.M., et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients. AIDS 18 (2004) F27-F36
6. Torriani F.J., Rodriguez-Torres M., Rockstroh J.K., Lissen E., Gonzalez-Garcia J., Lazzarin A., et al. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 351 (2004) 438-450
7. Alberti A., Clumeck N., Collins S., Gerlich W., Lundgren J.D., Palù G., et al. Short statement of the first European consensus conference on the treatment of chronic hepatitis B and C in HIV-coinfected patients. J Hepatol 42 (2005) 615-624
8. Strader D.B., Wright T., Thomas D.L., and Seeff L.B. Diagnosis, management, and treatment of hepatitis C. Hepatology 39 (2004) 1147-1171
9. Soriano V., Puoti M., Sulkowski M., Cargnel A., Benhamou Y., Peters M., et al. Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel. AIDS 21 (2007) 1073-1089
10. Tien P.C. Management and treatment of hepatitis C virus infection in HIV-infected adults: recommendations from the Veterans Affairs Hepatitis C Resource Center Program and National Hepatitis C Program Office. Am J Gastroenterol 100 (2005) 2338-2354
11. Benson C.A., Kaplan J.E., Masur H., Pau A., and Holmes K.K. Treating opportunistic infections among HIV-infected adults and adolescents. MMWR 53 (2004) 1-112
12. Butt A.A., Justice A.C., Skanderson M., Good C., and Kwoh C.K. Rates and predictors of hepatitis C virus treatment in HCV-HIV-coinfected subjects. Aliment Pharmacol Ther 24 (2006) 585-591
13. Zinkernagel A.S., von Wyl V., Ledergerber B., Rickenbach M., Furrer H., Battegay M., et al. Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort study. Antivir Ther 11 (2006) 131-142
14. Mehta S.H., Lucas G.M., Mirel L.B., Torbenson M., Higgins Y., Moore R.D., et al. Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic. AIDS 20 (2006) 2361-2369
15. Cacoub P., Halfon P., Rosenthal E., Pialoux G., Benhamou Y., Perronne C., et al. Treatment of hepatitis C virus in human immunodeficiency virus infected patients in "real life": Modifications in two large surveys between 2004 and 2006. J Hepatol 48 (2008) 35-42
16. Payan C., Pivert A., Morand P., Fafi-Kremer S., Carrat F., Pol S., et al. Rapid and early virological response to chronic hepatitis C treatment with IFN alpha-2b or PEG-IFN alpha-2b plus ribavirin in HIV/HCV co-infected patients. Gut 56 (2007) 1111-1116